PRWeb The Leader Press Release Distribution

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for September 5, 2008 Subscribe to this News Feed    
 

Lexi-Comp Provides Clinicians With Direct Links to PubMed

Lexi-Comp® ONLINE™ users can now access full text articles and other related materials

Hudson, Ohio (PRWEB) September 5, 2008 -- Lexi-Comp, Inc., a provider of clinical information to the healthcare industry, has added direct PubMed linking to Lexi-Comp ONLINE. Subscribers can now link directly to abstracts of the primary literature from the References field of monographs within this Web-based application. This enhancement allows clinicians to more quickly and effectively research information impacting patient care.

PubMed, a service of the U.S. National Library of Medicine, includes over 18 million citations from MEDLINE and other life science journals. PubMed includes links to full text articles and other related resources.

This linking is available within Lexi-Comp's core drug databases, Lexi-Drugs® and Pediatric Lexi-Drugs®.

Lexi-Drugs includes content that addresses all patient populations and covers clinical specialties such as cardiology, infectious disease, oncology, psychiatry, anesthesiology, and others. Monographs include up to 67 fields of information, such as Adverse Reactions, Drug Interactions, Contraindications, Dosing, Medication Safety Issues, Pharmacodynamics and Kinetics, and Special Alerts (including FDA boxed warnings).

Pediatric Lexi-Drugs® is designed for situations where pediatric dosing information is required and contains guidelines that have been researched and compiled by pediatric specialists. The database includes over 820 pediatric-sensitive drug monographs with detailed dosing guidelines for neonates, infants, and children.

In addition to these core drug databases, Lexi-Comp has added PubMed linking to databases that cover geriatric medications, infectious diseases, pharmacogenomics, lab and diagnostics, and natural products, all of which are accessible within Lexi-Comp ONLINE.

For more information on Lexi-Comp ONLINE, please call 1-800-837-5394 or visit http://www.lexi.com.

About Lexi-Comp
Lexi-Comp, Inc. provides clinical information solutions to the healthcare industry, publishing point-of-care content utilized in both in-patient and out-patient settings. These advanced resources help improve patient outcomes, medication safety, and workflow efficiency. Pharmacotherapy knowledge areas include drug information for adult, pediatric, and geriatric populations; medication interactions; laboratory tests and diagnostic procedures; pharmacogenomics; poisoning and toxicology; dentistry; infectious diseases; and patient education. Over 500,000 clinicians worldwide access Lexi-Comp's content via the Internet, mobile devices, and through integration with health information systems. An extensive library of print titles is also available. To learn more about Lexi-Comp's clinical information solutions, call 800.837.5394, 330.650.6506, or visit www.lexi.com.

Contact:
Heather Ciranna, Media Relations
Lexi-Comp, Inc.
800-837-5394
www.lexi.com

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1TdW1tLVpldGEtTG92ZS1QaWdnLVNpbmctWmVybw==

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Heather Ciranna
Lexi-Comp, Inc.
800-837-5394
Email us Here
Matt Snodgrass
Lexi-Comp, Inc.
800-837-5394
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appearshere.
 
Close Move